Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…


THE BUSINESS OF TECHNOLOGY
Immunotherapy company Harpoon Therapeutics has won a $70 million Series C funding round, with which it plans to expand its TriTAC and ProTriTAC platforms, the latter of which was unveiled just days…
It is a centuries-old image of good science: the lab-coated expert, hunched over a microscope analyzing a glass slide. Proscia wants to resign it to history – at least, when it comes…